Nutritional Supplements and Vitamins
Supplements and Depression and Bipolar
Research continues into the specifics of supplement use in major depressive disorder (MDD) and bipolar, with small studies coming out with suggestive results on a regular basis. Rigorous analysis of these studies usually shows only that “more research is needed” before recommendations for clinical use can be confidently issued. However, there are some results already becoming clear.
Omega-3 fatty acids are the dietary supplement with the most positive evidence for usefulness in some (but not all) situations. Folates (Vitamin B9) have not been shown to have any effect in treatment of mental disorders, with the exception of some evidence for high-dose methylfolate in treatment-resistant MDD. Vitamin D may provide some help in depression for those who are deficient in this vitamin but this is limited to those with a significant deficiency rather than a mild deficiency. See the sections below for more detail.
It should be emphasized that dietary supplements are not a replacement for following a healthy diet. People with mental illness are often found to have an excess consumption of high-fat and high-sugar foods, alongside inadequate intake of nutrient-dense foods, compared to the general population, and there is general agreement that a healthy diet is an important component, not only of physical health, but also in reducing the risk of mental illness and in management of mental illnesses when they occur. Nutrient supplementation can have helpful effects in specific cases, but it should not be seen as a cure-all.
We also have summarized data on the use of natural supplements for insomnia here…
Caveat Emptor – Let the Buyer Beware
For those who are interested in the topic and are concerned about the fact that there are no regulations to ensure that these products are safe and that they contain the ingredients they claim to contain, we strongly recommend visiting this website:
ConsumerLab.com, provides independent test results and information to help consumers and healthcare professionals evaluate health, wellness, and nutrition products. It publishes results of its tests online at www.consumerlab.com, including listings of brands that have passed testing. Products that pass CL’s testing are eligible to bear the CL Seal of Approval. CL addresses a growing need of consumers and healthcare professionals for better information to guide the selection of health, wellness, and nutrition products.
Supplements
Nutritional supplements and vitamins are chemicals that are found in nature (note: supplements don’t have to be any more “natural” in terms of how they are made than prescription drugs, they just have to contain chemicals which exist in nature). Because they are found in nature they are not, in the United States, subject to review and approval by the Food and Drug Administration. Also, because they are found in nature, they tend to be safer than prescription drugs (although that is not necessarily always true) and, at least in our experience, the effects of nutritional supplements and vitamins tend to be more subtle than the effects of medications, which increases the importance of tracking outcomes carefully (mood charting).
We believe in the value of supplements a great deal, but they are certainly not the right answer for everyone. What we have tried to do is summarize the available information on the supplements that have the most importance for those with mood disorders.
S-adenosylmethionine, or SAM-e for short, is one of the few nutritional supplements that has good clinical research to support its safety and effectiveness. Although SAM-e is used for many purposes, we are particularly interested in it as a compound that may have antidepressant properties.
A recent blog post on this site might also be worth reviewing.
Clinical Significance
S-adenosylmethionine (SAMe) is involved in many reactions that involve methylating chemicals (transferring a methyl group to the chemical to change its properties).
Two types of methylation reactions are particularly significant for psychiatry:
- Reactions involving Catechol-O-Methyl-Transferase (COMT)
- DNA Methyl-Transferase reactions
Catechol-O-Methyl-Transferase
COMT is one of the main enzymes involved in the breakdown of monoamine neurotransmitters which play a key role in depression (dopamine, norepinephrine, epinephrine).
For COMT to function there must be enough SAMe present.
There is some evidence to suggest that people with a particular form of the COMT enzyme (COMT Val158Met) may be more prone to fearfulness (paranoia) and excessive risk-taking (gambling, drug use), particularly when they are in exposed to high stress situations (“COMT Val158Met polymorphism interacts with stressful life events and parental warmth to influence decision making.” Qinghua He, Gui Xue, Chuansheng Chen, Zhong-Lin Lu, Chunhui Chen, Xuemei Lei, Yuyun Liu, Jin Li, Bi Zhu, Robert K. Moyzis, Qi Dong & Antoine Bechara. Nature Scientific Reports 2, Article number: 677 (2012) doi:10.1038/srep00677). Since this form of COMT is less active, people with this form of the enzyme who are experiencing these symptoms might respond to supplementation with SAMe which could overcome some of the reduced COMT activity.
DNA Methyl-Transferase
DNA Methyl-Transferases play a key role in regulating gene expression. Basically, at birth, a set of these enzymes apply methyl groups to selected locations on your genes. The methylation of the genes determines which genes are active and how active they are and thus plays a huge role in who you are as a person. Since the methylation of genes can be reversed, there is another set of these enzymes that maintain the methylation pattern. All of these DNA methyl-transferase reactions depend on SAMe.
Low Vitamin B12, Folate or Methionine
People with low vitamin B12 (fairly common in the elderly) or low folate or low levels of folate activity (which can be related to having a particular form of the enzyme methylenetetrahydrofolate reductase (MTHFR) may benefit from supplementation with SAMe since B12 and folate are all essential factors in the formation of SAMe in the body.
Clinical Effectiveness
Aside from the interesting possibility that SAMe may play a unique role in the treatment of irritability, paranoia and impulsiveness in people with the COMT Val158Met polymorphism, the use of SAMe that most people are interested in is its potential role in the treatment of depression.
SAMe is one of the most studied natural therapies for treating major depression. Several studies have shown that it is as effective as tricyclic antidepressants in treating major depression (Delle Chiaie, Am J Clin Nutr 2002, Salmaggi, Psychother Psychosom 1993, Kagan, Am J Psychiatry 1990). A more recent study (Papakostas, Am J Psychiatry 2010 clarified in Fleish, Am J Psychiatry 2010) found that it may be helpful in patients with major depressive disorder who did not respond to prescription treatment with a serotonin reuptake inhibitor (SRI). In the study, SAMe was given along with an SRI and 46.1% of patients receiving the combination benefited, versus 35.8% receiving an SRI and a placebo supplement. The results suggest that SAMe may be an effective and safe adjunctive treatment for SRI non-responders.
A recent article summarizing the literature on SAMe had this to say:
“SAMe is a methyl donor and is involved in the synthesis of various neurotransmitters in the brain. Derived from the amino acid L-methionine, SAMe has been postulated to have antidepressant properties. A small number of clinical trials with injected or oral SAMe have shown that, at doses of 200-1600 mg/d, SAMe is superior to placebo and is as effective as tricyclic antidepressants in alleviating depression, although some individuals may require higher doses. SAMe may have a faster onset of action than do conventional antidepressants and may potentiate the effect of tricyclic antidepressants. SAMe may also protect against the deleterious effects of Alzheimer disease. SAMe is well tolerated and relatively free of adverse effects, although some cases of mania have been reported in bipolar patients. Overall, SAMe appears to be safe and effective in the treatment of depression, but more research is needed to determine optimal doses.
“Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Mischoulon D, Fava M. Am J Clin Nutr. 2002 Nov;76(5):1158S-61S.Harvard Medical School, Depression Clinical and Research Program, Massachusetts General Hospital, Boston 02114, USA.
Our own experience is that SAMe is not entirely free of one side effect that can be of significant concern for those with bipolar (or manic depressive) disorder: It can definitely induce mania.
Therapeutic Dosages
A typical full dosage of SAMe is 400 mg taken 3 to 4 times per day If this dosage works for you, take it for a few weeks and then try reducing the dosage. As little as 200 mg twice daily may suffice to keep you feeling better once the full dosage has “broken through” the symptoms. However, some people develop mild stomach distress if they start full dosages of SAMe at once. To get around this, you may need to start low and work up to the full dosage gradually.
Recently, SAMe has come on the US market at a recommended dosage of 200 mg twice daily This dosage labeling makes SAMe appear more affordable (if you’re only taking 400 mg per day, you’ll spend only about a third or a fourth of what you’d pay for the proper dosage), but it is unlikely that SAMe will actually work when taken at such a low dosage.
Good sources of SAMe include: GNC, Natrol, Nature Made, Puritan’s Pride, Twinlab and the Vitamin Shoppe . It is often recommended that one start at 200 mg a day and then increase gradually to around 800 mg a day. SAMe should be taken in divided doses (at least 2 times a day and preferably 3 times a day) and improvement can be seen in a few days to 3-4 weeks.
Buyer beware! In its most recent review of these products, Consumer Lab found that almost half of all formulations were unacceptable. For one product the amount was below detectable.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease I am providing you with specific brand information as a courtesy. Gateway Psychiatric Services receives no reimbursement from these companies.
Ever since May of 1999, and the first publication of a study by Andy Stoll from Brigham and Women’s Hospital at Harvard Medical School, there has been a great deal of interest in the value of omega-3 fatty acids in the prevention and treatment of mood disorders.* The study compared 9.6 grams per day of omega-3 fatty acids from fish oil with olive oil (as a placebo) and found that, on nearly every measure, bipolar patients did better on the fish oil supplement.
Since then, there have been many more studies on fish oil supplementation in treatment of mental illnesses, and some significant results are beginning to emerge. A 2019 meta-analysis (Firth, et al. 2019) looked at 33 studies of nutrient supplementation in mental disorders, of which the use of omega 3 fatty acids as found in fish oil was an important sub-category. There are two major omega-3 fatty acids, ethyl-eicosapentaenoate (EPA), and docosahexaenoic acid (DHA). Of these, EPA has been shown to be the important factor in reducing depression in major depressive disorder and in bipolar depression. Recommended dosage is at least 2,200 mg (2.2 g) of EPA per day. No effect, either positive or negative, on mania has been found.
Fish oil supplementation has not been found to be effective in reducing the risk of depression in healthy populations, and it does not seem to have an effect on depression with comorbidities, (cardiometabolic or neurological diseases). It has been investigated as an adjunct to treatment with SSRI’s and also as a monotherapy, with use as an adjunctive treatment showing slightly better results. Omega-3 supplementation was not effective for MDD in pregnant women.
Our own experience with fish oil has been mixed: it seems to have helped patients with unstable or cycling mood disorders achieve more stability, but it is often not dramatically helpful. On the other hand, it has no side effects other than a very slight fishy “taste” that reminds you that you took it for a few minutes. And there is some evidence that it may be good for preventing blood vessel disease that can cause strokes, memory loss, and heart disease.
While fish oil can (and, if possible, should) be included in the diet, the higher doses of specific acids (EPA) will best be obtained through supplements. Care should be taken when purchasing supplements, and we always recommend subscribing to Consumer Labs (see above) if you are using dietary supplements. Fish oil, in particular, is subject to contamination and rancidity, so a reputable source is imperative. It is also recommended that you purchase fish oil in small amounts, and store it in the refrigerator, to prevent rancidity.
Saint John’s Wort ( Hypericum Perforatum ) is a plant that has a long (dating back to Hippocrates) history as an herbal medicine. It is commonly prescribed in Germany for the treatment of depression. A large, but mixed quality, literature, mostly from Germany, supports its use and suggests that it is comparably effective to traditional pharmaceutical antidepressants. It has not been shown to be effective for moderate to severe depression and one large study sponsored by the Pfizer did not find it to be more effective than placebo in the treatment of major depression (April 2002).
It is our experience that St. John’s Wort is a mildly effective antidepressant and, unlike SAMe, we have not seen it induce mania. However, most of the patients who have tried it with moderate or more severe depression have ended up switching to traditional antidepressants. It has a very mild side effect profile.
The form of Saint John’s Wort used in the NIMH study and in most research since then is available at Hypericum Buyer’s Club .**
While St. John’s Wort itself has a benign side effect profile, a potentially toxic metal, cadmium, is present in significant quantities in many formulations of the herb. Also, there is a great deal of variability in the quality of product available. Nature Made and Nature’s Plus are two other formulations that are of generally good quality. The optimum dosage of hypericum, based on the majority of medical studies, is 300 mg of hypericum extract three times a day.
Finally, research from the NIH has shown that St. John’s wort interacts with some drugs–including certain drugs used to control HIV infection (such as indinavir). Other research shows that St. John’s wort can interact with anticancer, or chemotherapeutic, drugs (such as irinotecan). The herb may also interact with drugs that help prevent the body from rejecting transplanted organs (such as cyclosporine). Using St. John’s wort limits these drugs’ effectiveness.
Melatonin is a hormone made by your body’s pineal (pih-knee-uhl) gland. When the sun goes down, and darkness comes, the pineal gland “goes to work.” As melatonin production rises, you begin to feel less alert. Body temperature starts to fall as well. Levels are so low during the day that scientists often have difficulty detecting melatonin then.
Few studies have been done on melatonin’s safety, side effects, interactions with drugs, and long-term effects. (Unlike products recognized as “drugs, melatonin does not require extensive testing in animals and people before being sold in the U.S.). How much to take, when to take it, and melatonin’s effectiveness for many groups of people are also unknown.
Our experience is that melatonin is an agent that is not a particularly effective sedative (in other words it doesn’t help that much putting you to sleep), however it can help to re-establish normal circadian (night/day) biorhythms. An alternative approach, that has no side effects at all involves calculating when to expose yourself to light use a jet lag bodyclock .
For more information on melatonin see these blog posts –
Natural Supplements and Vitamins for Insomnia
Those of you who are interested in trying this agent are in luck because the quality of melatonin supplements available is generally pretty good. Natrol, Twinlab, Puritan’s Pride and Walgreen’s are among the companies with good products.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease I am providing you with specific brand information as a courtesy. Gateway Psychiatric Services receives no reimbursement from these companies.
For a number of reasons, some obvious, and some not so obvious, many people with mood disorders have trouble eating a healthy diet. At the same time, there is very strong evidence that vitamin deficiencies are related to depression. For this reason, we strongly urge everyone with a mood disorder to at least take a multivitamin every day.
In the sections that follow we will talk a little bit more about the role that various vitamins play in preserving normal mood.
Multivitamin / Multimineral Pills
We recommend that every patient with a mood disorder take a multivitamin / multimineral pill. There are many reasons for this. First, they are inexpensive and safe (with a few exceptions relating to formulations that provide too much of certain vitamins or minerals — those that provide 100% of the Daily Value of vitamins or minerals are always fine). Second, there are a number of deficiencies that can worsen depression, and that may even make a depression resistant to other kinds of treatment, for instance folate deficiency and iron deficiency.
However, a recent test of multivitamins by Consumer Labs (see above) found that 25% failed to meet acceptable standards. Some contained potentially toxic levels of lead in them. Formulations made by Walgreen’s, Puritan’s Pride, GNC and Centrum all passed the tests.
Some general advice:
- A multi need not cost more than a few cents a day. You don’t need a fancy multi.
- Look for “USP” on the product label. This means that the pills meet the standards of the US Pharmacopeia for disintegration and it also means that it has been tested under controlled laboratory conditions.
- Look for 100% of the Daily Value for: vitamin D, vitamin B1 (thiamin), B2 (riboflavin), B3 (niacin), B6, B12 and folic acid (folate). Plus at least 20 micrograms of vitamin K for strong bones.
- The multivitamin should contain no more than 5,000 IU of vitamin A (that’s 100% of the Daily Value) but at least 40% of it should be in the form of beta carotene.
- Look for 100% of the Daily Value of: copper, zinc, iodine, selenium (preferably from yeast, but not more than 200 micrograms) and chromium (not more than 200 micrograms).
- Most multivitamins contain 100% of the Daily Value of vitamin C and E. This may not be enough. We recommend 250 – 500 milligrams of vitamin C per day, but you should get the extra amount from fruits (orange juice) and vegetables (orange and red vegetables) if possible. It is not clear whether higher doses of vitamin E are helpful or not.
- Calcium is so bulky that you won’t be able to find a multi with enough, so you will probably need a separate calcium supplement. Everyone needs at least 1,000 milligrams of calcium per day in either a supplement or in food. Women over 50 and men over 65 need 1,200 to 1,5000 mg.
- If your multi contains iron (and it should) don’t take it with food.
Good sources of multivitamins include: Geritol, Kirkland Signature, Nature Made, Nature’s Bounty, One A Day Maximum, Theragran-M, Centrum and Walgreen’s Multivitamin with Iron. Consumer Labs tested multivitamins in September 2000. Their review can be found at ConsumerLabs.com.* In this study 5/15 multivitamins failed their standards.
B Vitamins
There are eight B vitamins:
- thiamine (B1)
- riboflavin (B2)
- niacin (B3)
- pantothenic acid (B5)
- pyridoxine (B6)
- biotin (B7)
- folate (folic acid, B9)
- cobalamin (B12)
Like most vitamins, B vitamins must be consumed in diet or supplements because your body needs them but cannot make them.
Three of the B vitamins have a particularly important role in brain function in depression: pyridoxine (B6), folate (B9) and cobalamin (B12). In addition, thiamine (B1) deficiency, especially in people who drink heavily, can be associated with memory deficits, and in one small study thiamine supplementation was found to speed up response to serotonin antidepressants (SSRIs).
Pyridoxine (B6)
In one study, treatment with B6 (50 mg) was found to help women deficient in B6 who had depression associated with use or oral contraceptives, but it has generally not helped other people suffering from depression and this study was a small one (Williams, American Journal of Psychiatry 1973). A number of the studies that have looked at using combinations of B vitamins to help prevent cognitive decline and memory problems in the elderly have included B6, which is why we included it here in the list of important B vitamins for the brain.
Folic Acid and Methylfolate (B9)
A consistent finding in major depression has been a low plasma and red cell folate which has also been linked to poor response to antidepressants. Several studies have also found that supplementation with at least 500 micrograms of folate converted some antidepressant nonresponders into good responders.
Folate deficiency is associated with depression and dementia. It is also a critical supplement for women who are pregnant. And some medications (especially Depakote and Lamictal) that may be prescribed to patients with mood disorders tend to inhibit the action of folate.
Although the review on nutritional supplements did not find convincing evidence for the effectiveness of folate supplements, there may be a particular circumstance in which some kind of supplement may be especially useful, some people have a genetic variant of the methylenetetraheydrofolate reductase (MTHFR) gene that puts them at greater risk of a deficit in folate in the brain.
For more on this read this blog post –
We have found that methylfolate supplements are more likely to be helpful in those with this genotype, which can be identified using a panel of genetic tests that we often use in patients who fail to respond to initial treatments of depression (the Genocept assay).
Methylfolate is the active form of folate. Folate is the form found in the diet and in most over the counter supplements, but for people with the deficient MTHFR gene, they are not able to convert folate to methylfolate and transport it into the brain, where it is used to make many of the essential neurotransmitters that affect depression.
Folic acid also has particular affects on mood and cognitive and social function. However, folic acid should be used with caution in the presence of vitamin B-12 deficiency or epilepsy. The easiest way to get your daily dose is by taking a daily multivitamin.
Good natural sources of folate include dark green leafy vegetables and oranges.
The recommended daily allowance for most adults is 400 mcg, but for pregnant women it is 600 mcg per day. The upper limit for folic acid is 1000 mcg per day, however, some studies have found benefit at higher doses, at higher doses, though there is some reason for concern about toxicity because folate can make the brain more vulnerable to seizures. More information is available here.
Cyanocobalamin (B12)
B12 deficiency is one of the classic causes of a potentially reversible memory impairment. Most people receive adequate amounts from their diet (it is found in meats, fish, and chicken, but not found in foods from plants) but vegetarians (for obvious reasons) and those who are older than 50 years of age (because of reduced stomach acid and therefore reduced absorption) should take supplements.
The role of B12 in minimizing cognitive decline is suggested by a study which followed several hundred people in their 70’s over an eight year period and found that cognitive decline was faster among those with the lowest blood levels of B12 (under 257 pmol/L) which was the case for 40% of the elderly people in the study (Morris, J Am Geriatr Soc 2012). Normally, people are not considered B12 deficient (and at risk for pernicious anemia) until levels go below about 148 pmol/L (200 pg/mL). The study suggests that it may be beneficial to maintain somewhat higher levels of B12.
Similarly, a large placebo-controlled study in Holland of adults 65 and older suggested that blood levels of B12, particularly in its active form, holotranscobalamin, may indicate who can most benefit from supplementing with B vitamins. In this study, all participants had high homocysteine levels (12 to 50 micromol/L) although many were not actually deficient in B12 (the mean level was 257 pmol/L). After being given folic acid (400 mcg) and B12 (500 mcg) daily for 2 years, compared to placebo, there was a minor reduction in the decline in cognitive functioning. However, those who started the study with lower levels of holotranscobalamin (below 64 pmol/L) had more benefit from supplementation in terms of episodic memory performance (i.e., recall and recognition) and information processing speed (van der Zwaluw, Neurology 2014).
The recommended daily allowance is 2.4 micrograms for most people, but higher doses of up to 500 mcg have been used to prevent heart disease. No upper limit has been established for B12.
Since some older people lack the co-factor that facilitates absorption of B12 we sometimes find it useful to prescribe either B12 injections or an intranasal form of B12 (Nascobal).
B Vitamin Combinations
Not surprisingly, a number of studies have looked at B vitamin combinations as a way to prevent or minimize cognitive deficits in older patients.
In a 2 year placebo controlled study of people aged 70 years or older with mild cognitive impairment, a combination of B vitamins was found to slow cognitive decline, particularly in those who started with elevated levels of plasma homocysteine (over 11.3 micromoles/L) which can occur with inadequate B vitamin intake. People in the study were given a daily dose of folic acid (800 mcg), vitamin B12 (500 mcg), and vitamin B6 (20 mg) (de Jager, Int J Geriatr Psy 2011). Further analyses of this study found that the beneficial effects of B vitamins were enhanced when people began the study with blood plasma levels of omega 3 fatty acids in the upper range of normal, In fact, those with low omega 3 levels did not benefit from B vitamin supplementation. In general, the effects were more significant for DHA alone than for EPA the combined levels (Oulhaj, J Alz Dis 2016).
In a similar study, this same B vitamin combination reduced the amount of shrinkage in regions of the brain commonly affected by Alzheimer’s disease. The benefit was found only among people who started the 2 year study with high homocysteine levels (over 11.06 micromoles/L), but this represented about 50% of the people in the study. Shrinkage was reduced by 8 times compared to the amount of brain shrinkage experienced among those taking placebo (Douaud, PNAS 2013). As with the research noted above by Oulhaj, further analysis of this study also found that higher blood levels of omega 3 fatty acids enhanced the beneficial effect of the B vitamins (Jerneren, Am J Clin Nutr 2015).
In summary, it is reasonable in those concerned with cognitive decline to receive testing for the level of plasma homocysteine in your blood, and if this is elevated, it makes sense to take a combination of 800 mcg of folate (or one of the active forms of folate discussed above) along with 500 mcg of vitamin B12 (or Nascobal) and 20 mg of vitamin B6 plus fish oil.
Vitamin D
Vitamin D is a fat-soluble vitamin, unlike the B vitamins that we have been talking about, and fat-soluble vitamins generally require more care with dosing because they can accumulate in fat and reach toxic levels in the body.
This means that vitamin D has a “therapeutic window” – take too much and you suffer adverse consequences just as you do if you have too little.
In addition, there was some controversy about what constitutes a “normal” level of the vitamin in blood. This has largely been resolved and we now understand that there is a normal level for 25-hydroxy vitamin D, which is between 20 nanograms/milliliter to 50 ng/mL, but then there is a level between 12 and 20 nanograms/milliliter which may not be quite “normal” but where supplementation is unlikely to be necessary or beneficial and it’s really only those people below a level of 12 nanograms/milliliter who need and benefit from supplementation.
All of this means that vitamin D supplementation really needs to be guided by blood tests and initiated only if there’s evidence of a deficiency.
A study reported by WebMD in June 2017 suggests that many Americans may be getting too much of the vitamin:
“In 2014, just over 3 percent of U.S. adults took more than 4,000 international units (IUs) of the vitamin daily, exceeding the upper limits of what is considered safe, the researchers said. In 2007-2008, only 0.2 percent did that.
For perspective, the recommended daily amount of vitamin D is only 600 IUs for adults aged 70 and younger. For those over 70, the recommendation is 800 IUs a day.
“More may not always be better with vitamin D,” said study author Mary Rooney, a doctoral student at the University of Minnesota in Minneapolis.
“There’s not much research on longer-term health outcomes on high-dose supplements,” she said. But studies have hinted at potential harm, such as excess calcium in the blood, which can cause deposits in blood vessels, Rooney and her colleagues said.”
Curcumin is the bright yellow curcuminoid compound that is found in turmeric (Curcuma longa), a member of the ginger family. It is a diarylheptanoid that belongs to the group curcuminoids, which are phenolic pigments and are responsible for the yellow color of turmeric. It is often sold as a food flavoring, food coloring, cosmetics ingredient and herbal supplement.
Links to more information about Curcumin and its uses as a supplement.
Curcumin for musculoskeletal pain
Curcumin affects these inflammatory markers
Curcumin and depression, cognition, Alzheimer’s dx
Curcumin and neuroinflammation in general
Link to Curcumin updates, side effects and cautions here:
Turmeric and Curcumin Supplements and Spices Review
Curcumin Formula Options
CURCUMIN – MERIVA FORMULATION
CurcumaSorb (Meriva) 180 caps (MCU1)
250 mg caps 1 twice daily w/ or w/o food for a week then 2 twice daily thereafter.
~~~
If you prefer soy-free
Thorne Research – Meriva SF (Soy Free) – Sustained-Released Curcumin Phytosome Supplement (T94844)
250 mg caps 1 twice daily w/ food for a week then 2 twice daily preferably on an empty stomach.
OR for savings on the soy-free option choose larger capsules
Thorne Research – Meriva 500-SF (Soy Free) – Curcumin Phytosome Supplement (T94790)
500 mg caps 1 daily w/o or w/o food for a wk then 1 twice daily thereafter.
If after 2–3 weeks at 2 caps twice daily you feel some relief but need more, you may double your dose.
NOTE that curcumin may bind to iron and reduce availability of that nutrient.
If you are anemic or have low iron stores, or a history of this, remind me to add an iron panel to your lab order after you have been taking this for three months.
Rarely, curcumin has caused elevated liver values.
How it works: curcumin is a poison, a pesticide the turmeric plant makes. It works through hormesis – small amount of harm = great amount of good, same as with exercise. Exercise causes stress and spikes inflammation, but helps us to express genes that are anti-inflammatory and that aid in resilience. So does curcumin. The Meriva formulation attaches it to a fat globule from plants called a phytosome, which is attached to your cell walls, allowing the curcumin to enter and work without being rejected. The formula aids in introduction and in helping it stick long enough to work, which makes it possible to deliver enough help in a small amount of product.
CURCUMIN – XYMOGEN BCM-95 FORMULATION
Xymogen’s BCM-95 product is superior to Meriva, but you will need to visit the Xymogen store to get it separately.
To order from Xymogen at Wholescripts, visit https://wholescripts.com/register, and make an account using the referral code BayPsych and the last name, Hoepner.
CurcuPlex-95™ 120 Capsules – 1 twice daily with food
Do not order the CurcuPlex that contains bioperine, which inhibits the enzyme CYP3A4, inhibiting clearance of toxins and many drugs
Why Xymogen BCM-95:
-
- Full-spectrum product:
- BCM-95 are tumerones that give the smell and color to turmeric; these are purified and isolated, added back into the curcumin product which is extractable (not spice) grade. No industrial solvents used, only food grade.
- Also includes THC – tetrahydrocurcumin
With curcumin, you want to increase free (not total) curcumin.
-
- The free curcumin levels available in the CurcuPlex-95 are far greater than those in Meriva or other formulations, including other BCM-95 products.
- Yes Meriva increases curcumin bioavailability 29 fold, but it has much less curcumin in it in the first place, such that the amount of bioavailable *free* curcumin still is around 1/5 that of what is offered by the Xymogen product.
- Also this is sustained in the blood for 8 hrs, vs 4.5 hrs with average other products.
- If you get the product that binds the curcumin to monoglyceride (Monopure) fish oil, you get best absorption across cell membranes, but only 125 mg curcumin per serving, vs 500 with CurcuPlex-95.
CURCUMIN – TESSERACT FORMULATION
TetraCumin QR
Order at Fullscript
400 mg caps 1 twice daily w/ or w/o food
~~~
If after 2–3 weeks at 2 caps twice daily you feel some relief but need more, you may increase your dose to 3 or 4 caps daily
NOTE that curcumin may bind to iron and reduce availability of that nutrient.
If you are anemic or have low iron stores, or a history of this, remind me to add an iron panel to your lab order after you have been taking this for three months.
Rarely, curcumin has caused elevated liver values.
How it works: curcumin is a poison, a pesticide the turmeric plant makes. It works through hormesis – small amount of harm = great amount of good, same as with exercise. Exercise causes stress and spikes inflammation, but helps us to express genes that are anti-inflammatory and that aid in resilience. So does curcumin. The Meriva formulation attaches it to a fat globule from plants called a phytosome, which is attached to your cell walls, allowing the curcumin to enter and work without being rejected. The formula aids in introduction and in helping it stick long enough to work, which makes it possible to deliver enough help in a small amount of product.
de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012 Jun;27(6):592-600. doi: 10.1002/gps.2758. Epub 2011 Jul 21. PubMed PMID: 21780182.
Ghaleiha, A., Davari, H., Jahangard, L. et al. Eur Arch Psychiatry Clin Neurosci (2016). doi:10.1007/s00406-016-0685-6
Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J Am Geriatr Soc. 2012 Aug;60(8):1457-64. doi: 10.1111/j.1532-5415.2012.04076.x. Epub 2012 Jul 12. PubMed PMID: 22788704; PubMed Central PMCID: PMC3419282.
Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2015;50(2):547-57. doi: 10.3233/JAD-150777. PubMed PMID: 26757190; PubMed Central PMCID: PMC4927899.
van der Zwaluw NL, Dhonukshe-Rutten RA, van Wijngaarden JP, Brouwer-Brolsma EM, van de Rest O, In ‘t Veld PH, Enneman AW, van Dijk SC, Ham AC, Swart KM, van der Velde N, van Schoor NM, van der Cammen TJ, Uitterlinden AG, Lips P, Kessels RP, de Groot LC. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology. 2014 Dec 2;83(23):2158-66. doi: 10.1212/WNL.0000000000001050. Epub 2014 Nov 12. PubMed PMID: 25391305.
Williams AL, Cotter A, Sabina A, Girard C, Goodman J, Katz DL. The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract. 2005 Oct;22(5):532-7. Epub 2005 Jun 17. Review. PubMed PMID: 15964874.
Palmer. Christopher M. Diets and Disorders: Can Foods or Fasting Be Considered Psychopharmacologic Therapies? J Clin Psychiatry 81:1, January/February 2020. https://doi.org/10.4088/JCP.19ac12727